Franklin Genomic Advancements ETF’s (HELX) Moving Averages Convergence Divergence (MACD) indicator is -0.54, suggesting Franklin Genomic Advancements ETF is a Sell.
Franklin Genomic Advancements ETF’s (HELX) 20-Day exponential moving average is 35.14, making it a Sell.
Franklin Genomic Advancements ETF’s (HELX) 50-Day exponential moving average is 35.66, making it a Sell.